Sepracor, Inc. Release: OMNARIS(TM) Nasal Spray Now Available by Prescription for Patients with Seasonal and Perennial Allergies

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced that OMNARIS™ (ciclesonide) Nasal Spray is now available by prescription in pharmacies nationwide. OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older, and with perennial allergic rhinitis in adults and adolescents 12 years of age and older.

MORE ON THIS TOPIC